
Supplements and Featured Publications
- Glaucoma 360: Highlights from 2020
Glaucoma 360: Lowering IOP using the MIMS solution
ICYMI: Nir Israeli, co-founder and CEO of Sanoculis discusses the company's new alternative surgical procedure for glaucoma designed to create a single-patient-use sterile tool and a multi-use external machine.
ICYMI: Nir Israeli, co-founder and CEO of Sanoculis discusses the company's new alternative surgical procedure for glaucoma called MIMS — Minimally Invasive Micro Sclerostomy — solution, designed to create a single-patient-use sterile tool and a multi-use external machine, during the 2020 Glaucoma 360 meeting in San Francisco, California.
Articles in this issue
almost 6 years ago
Assessing the angle: Getting back to basicsalmost 6 years ago
OCTA: The jury is still outalmost 6 years ago
Funding new technologies for glaucoma treatmentalmost 6 years ago
Glaucoma drug delivery devices enter new frontieralmost 6 years ago
Glaucoma devices: Now and in the futurealmost 6 years ago
Beating burnout with camaraderiealmost 6 years ago
Status of glaucoma: diagnostics and treatments in fluxalmost 6 years ago
Next frontier in glaucoma: Beyond IOP-lowering treatmentsalmost 6 years ago
Normal tension glaucoma: testing diagnostic skillsalmost 6 years ago
Diagnostics: Innovative ways of looking at glaucoma






















